Generated by Llama 3.3-70Bamoxicillin is a penicillin-based antibiotic used to treat various bacterial infections, including those caused by Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli. It is often prescribed by doctors and physicians at hospitals such as Massachusetts General Hospital and Johns Hopkins Hospital. Pharmacists at CVS Pharmacy and Walgreens typically dispense amoxicillin to patients diagnosed with pneumonia or bronchitis by specialists like pulmonologists at Mayo Clinic and Cleveland Clinic.
amoxicillin is a semisynthetic antibiotic derived from penicillin, developed by Beecham Group and first introduced in the United Kingdom in 1972. It is commonly used to treat infections of the respiratory tract, skin and soft tissue infections, and urinary tract infections caused by bacteria such as Staphylococcus aureus and Klebsiella pneumoniae. Researchers at Harvard University and Stanford University have studied the effectiveness of amoxicillin in treating various infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA). Scientists at National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) have also investigated the use of amoxicillin in combination with other antibiotics, such as clavulanic acid, to treat infections caused by beta-lactamase-producing bacteria.
The mechanism of action of amoxicillin involves inhibiting the synthesis of the bacterial cell wall, ultimately leading to the death of the bacteria. This is achieved by binding to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, such as PBP2a in Staphylococcus aureus. Biochemists at University of California, Berkeley and University of Oxford have studied the interaction between amoxicillin and PBPs, including PBP1a and PBP1b in Escherichia coli. The use of amoxicillin has been recommended by infectious disease specialists at Infectious Diseases Society of America (IDSA) and European Centre for Disease Prevention and Control (ECDC) for the treatment of various bacterial infections, including those caused by Streptococcus pyogenes and Haemophilus parainfluenzae.
amoxicillin is used to treat a wide range of bacterial infections, including pneumonia, bronchitis, sinusitis, and urinary tract infections. It is also used to treat skin and soft tissue infections caused by Staphylococcus aureus and Streptococcus pyogenes. Dentists at American Dental Association (ADA) and British Dental Association (BDA) often prescribe amoxicillin to treat dental infections caused by bacteria such as Fusobacterium nucleatum and Porphyromonas gingivalis. Additionally, amoxicillin is used to treat infections caused by Helicobacter pylori in patients with peptic ulcer disease, as recommended by gastroenterologists at American Gastroenterological Association (AGA) and European Gastrointestinal Motility Society (EGMS).
Common side effects of amoxicillin include nausea, vomiting, and diarrhea, which can be managed by gastroenterologists at Cedars-Sinai Medical Center and University of California, Los Angeles (UCLA). More serious side effects, such as allergic reactions and Clostridioides difficile (C. diff) infection, can occur in rare cases, and require immediate attention from emergency medicine specialists at Emergency Nurses Association (ENA) and Society for Academic Emergency Medicine (SAEM). Pharmacologists at University of Michigan and University of Pennsylvania have studied the side effect profile of amoxicillin and its potential interactions with other medications, such as warfarin and phenytoin.
The pharmacokinetics of amoxicillin involve its absorption, distribution, metabolism, and excretion. amoxicillin is absorbed in the gastrointestinal tract and distributed to various tissues, including the lungs, liver, and kidneys. It is metabolized by enzymes in the liver, such as cytochrome P450, and excreted in the urine by nephrologists at National Kidney Foundation (NKF) and American Society of Nephrology (ASN). Clinical pharmacologists at University of California, San Francisco (UCSF) and Duke University have studied the pharmacokinetics of amoxicillin in various patient populations, including pediatric patients and geriatric patients.
The development of amoxicillin began in the 1960s at Beecham Group, where scientists such as George Rolinson and Robert Nayler worked on developing new antibiotics. The first clinical trials of amoxicillin were conducted in the early 1970s at hospitals such as St. Bartholomew's Hospital and Guy's Hospital. amoxicillin was approved for use in the United States in 1974 by the Food and Drug Administration (FDA) and has since become a widely used antibiotic in the treatment of various bacterial infections. Historians at Wellcome Trust and National Library of Medicine have documented the history of amoxicillin and its impact on the treatment of infections caused by bacteria such as Streptococcus pneumoniae and Haemophilus influenzae】]. Category:Antibiotics